Año 2017 / Volumen 109 / Número 7
Editorial
Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer

483-484

DOI: 10.17235/reed.2017.5107/2017

David Mansouri,

Resumen
Screening for colorectal cancer is now integrated into the fabric of healthcare systems across the world, as a wealth of evidence exists as regards its benefits in reducing cancer-specific mortality through the detection of early-stage disease. Options for screening include both endoscopic and stool-based tests, with a majority of countries opting for repeated faecal occult blood screening tests (FOBt). These can be either guaiac-based, as is the current system across the UK, or immunoglobulin-based, as is the case in the accompanying article from Spain. Patients testing positive for FOBt proceed to colonoscopy, where a relatively small proportion of patients, less than 10% in established screening programmes, will have a colorectal cancer identified. As national programmes have developed, multiple publications have focused on the differing aspects between colorectal cancers diagnosed through screening programmes (SD) and those diagnosed outside the screening pathway (NSD). In particular, patients diagnosed with SD tumours have been noted to be younger, more likely to be male and less socioeconomically deprived. Furthermore, tumour characteristics are different with early-stage disease and an absence of rectal tumours predominating in the SD patient group.
Nuevo comentario
Comentarios
No hay comentarios para este artículo.
Bibliografía
1. Hewitson P, Glasziou P, Watson E, et al. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 2008;103(6):1541-9 doi: 10.1111/j.1572-0241.2008.01875.x[published Online First: Epub Date]|.
2. Sebastian E, Courtier R, Macia F, et al. The impact of screening on short-term outcome after surgery for colorectal cancer. Rev Esp Enfern Dig 2017.
3. Logan RF, Patnick J, Nickerson C, et al. Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests. Gut 2012;61(10):1439-46 doi: 10.1136/gutjnl-2011-300843[published Online First: Epub Date]|.
4. Morris EJ, Whitehouse LE, Farrell T, et al. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme. Br J Cancer 2012;107(5):757-64 doi: 10.1038/bjc.2012.331[published Online First: Epub Date]|.
5. Mansouri D, McMillan DC, McIlveen E, et al. A comparison of tumour and host prognostic factors in screen-detected vs nonscreen-detected colorectal cancer: a contemporaneous study. Colorectal Dis 2016;18(10):967-75 doi: 10.1111/codi.13295[published Online First: Epub Date]|.
6. Leung E, McArdle K, Wong LS. Risk-adjusted scoring systems in colorectal surgery. Int J Surg 2011;9(2):130-5 doi: S1743-9191(10)00480-2 [pii]
7. Tekkis PP, Prytherch DR, Kocher HM, et al. Development of a dedicated risk-adjustment scoring system for colorectal surgery (colorectal POSSUM). Br J Surg 2004;91(9):1174-82 doi: 10.1002/bjs.4430[published Online First: Epub Date]|.
8. Ferjani AM, Griffin D, Stallard N, et al. A newly devised scoring system for prediction of mortality in patients with colorectal cancer: a prospective study. Lancet Oncol 2007;8(4):317-22 doi: 10.1016/S1470-2045(07)70045-1[published Online First: Epub Date]|.
9. Nazha B, Moussaly E, Zaarour M, et al. Hypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate? World journal of gastrointestinal surgery 2015;7(12):370-7 doi: 10.4240/wjgs.v7.i12.370[published Online First: Epub Date]|.
10. Roxburgh CS, Platt JJ, Leitch EF, et al. Relationship between preoperative comorbidity, systemic inflammatory response, and survival in patients undergoing curative resection for colorectal cancer. Ann Surg Oncol 2011;18(4):997-1005 doi: 10.1245/s10434-010-1410-8[published Online First: Epub Date]|.
11. Moyes LH, Leitch EF, McKee RF, et al. Preoperative systemic inflammation predicts postoperative infectious complications in patients undergoing curative resection for colorectal cancer. Br J Cancer 2009;100(8):1236-9 doi: 10.1038/sj.bjc.6604997[published Online First: Epub Date]|.
12. Platt JJ, Ramanathan ML, Crosbie RA, et al. C-reactive protein as a predictor of postoperative infective complications after curative resection in patients with colorectal cancer. Ann Surg Oncol 2012;19(13):4168-77 doi: 10.1245/s10434-012-2498-9[published Online First: Epub Date]|.
Instrucciones para citar
Mansouri D. Lower morbidity and improved outcomes in patients with screen-detected colorectal cancer. 5107/2017


Descargar en un gestor de citas

Descargue la cita de este artículo haciendo clic en uno de los siguientes gestores de citas:

Métrica
Este artículo ha sido visitado 334 veces.
Este artículo ha sido descargado 147 veces.

Estadísticas de Dimensions


Estadísticas de Plum Analytics

Ficha Técnica

Recibido: 05/06/2017

Aceptado: 19/06/2017

Prepublicado: 26/06/2017

Publicado: 30/06/2017

Tiempo de prepublicación: 21 días

Tiempo de edición del artículo: 25 días


Compartir
Este artículo ha sido valorado por 1 lectores .
Valoración del lector:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
La REED es el órgano oficial de la Sociedad Española de Patología Digestiva, la SociedadEspañola de Endoscopia Digestiva y la Asociación Española de Ecografía Digestiva
Política de cookies Política de Privacidad Aviso Legal © Copyright 2026 y Creative Commons. Revista Española de Enfermedades Digestivas